Exelixis
EXEL
#1589
Rank
NZ$24.35 B
Marketcap
NZ$96.89
Share price
2.89%
Change (1 day)
33.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company